One report describing 41 cases of COVID-19 indicated that prolonged prothrombin time, elevated D-dimer, and severe platelet reduction occur in critical COVID-19 patients [28], all of which are associated with increased propensity for haemorrhagic complications. The gene discussed is F2; the disease is COVID-19.